6.
Steptoe A, Breeze E, Banks J, Nazroo J
. Cohort profile: the English longitudinal study of ageing. Int J Epidemiol. 2012; 42(6):1640-8.
PMC: 3900867.
DOI: 10.1093/ije/dys168.
View
7.
Blodgett J, Perez-Zepeda M, Godin J, Kehler D, Andrew M, Kirkland S
. Prognostic accuracy of 70 individual frailty biomarkers in predicting mortality in the Canadian Longitudinal Study on Aging. Geroscience. 2024; 46(3):3061-3069.
PMC: 11009196.
DOI: 10.1007/s11357-023-01055-2.
View
8.
Stolz E, Mayerl H, Godin J, Hoogendijk E, Theou O, Freidl W
. Reliability of the Frailty Index Among Community-Dwelling Older Adults. J Gerontol A Biol Sci Med Sci. 2023; 79(2).
PMC: 10809054.
DOI: 10.1093/gerona/glad227.
View
9.
Nguyen Q, Moodie E, Keezer M, Wolfson C
. Clinical Correlates and Implications of the Reliability of the Frailty Index in the Canadian Longitudinal Study on Aging. J Gerontol A Biol Sci Med Sci. 2021; 76(11):e340-e346.
PMC: 8514068.
DOI: 10.1093/gerona/glab161.
View
10.
Ward D, Ranson J, Wallace L, Llewellyn D, Rockwood K
. Frailty, lifestyle, genetics and dementia risk. J Neurol Neurosurg Psychiatry. 2021; 93(4):343-350.
PMC: 8921595.
DOI: 10.1136/jnnp-2021-327396.
View
11.
Howlett S, Rutenberg A, Rockwood K
. The degree of frailty as a translational measure of health in aging. Nat Aging. 2023; 1(8):651-665.
DOI: 10.1038/s43587-021-00099-3.
View
12.
Li G, Larson E, Shofer J, Crane P, Gibbons L, McCormick W
. Cognitive Trajectory Changes Over 20 Years Before Dementia Diagnosis: A Large Cohort Study. J Am Geriatr Soc. 2017; 65(12):2627-2633.
PMC: 5729097.
DOI: 10.1111/jgs.15077.
View
13.
Boyle P, Yu L, Leurgans S, Wilson R, Brookmeyer R, Schneider J
. Attributable risk of Alzheimer's dementia attributed to age-related neuropathologies. Ann Neurol. 2018; 85(1):114-124.
PMC: 10128614.
DOI: 10.1002/ana.25380.
View
14.
Sabia S, Dugravot A, Dartigues J, Abell J, Elbaz A, Kivimaki M
. Physical activity, cognitive decline, and risk of dementia: 28 year follow-up of Whitehall II cohort study. BMJ. 2017; 357:j2709.
PMC: 5480222.
DOI: 10.1136/bmj.j2709.
View
15.
Dubois B, Hampel H, Feldman H, Scheltens P, Aisen P, Andrieu S
. Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria. Alzheimers Dement. 2016; 12(3):292-323.
PMC: 6417794.
DOI: 10.1016/j.jalz.2016.02.002.
View
16.
Canevelli M, Arisi I, Bacigalupo I, Arighi A, Galimberti D, Vanacore N
. Biomarkers and phenotypic expression in Alzheimer's disease: exploring the contribution of frailty in the Alzheimer's Disease Neuroimaging Initiative. Geroscience. 2020; 43(2):1039-1051.
PMC: 8110661.
DOI: 10.1007/s11357-020-00293-y.
View
17.
Diebel L, Rockwood K
. Determination of Biological Age: Geriatric Assessment vs Biological Biomarkers. Curr Oncol Rep. 2021; 23(9):104.
PMC: 8284182.
DOI: 10.1007/s11912-021-01097-9.
View
18.
Ward D, Wallace L, Rockwood K
. Cumulative health deficits, genotype, and risk for later-life mild cognitive impairment and dementia. J Neurol Neurosurg Psychiatry. 2020; 92(2):136-142.
PMC: 7841490.
DOI: 10.1136/jnnp-2020-324081.
View
19.
Stolz E, Mayerl H, Hoogendijk E, Armstrong J, Roller-Wirnsberger R, Freidl W
. Acceleration of health deficit accumulation in late-life: evidence of terminal decline in frailty index three years before death in the US Health and Retirement Study. Ann Epidemiol. 2021; 58:156-161.
DOI: 10.1016/j.annepidem.2021.03.008.
View
20.
Melo Dos Santos L, Trombetta-Lima M, Eggen B, Demaria M
. Cellular senescence in brain aging and neurodegeneration. Ageing Res Rev. 2023; 93:102141.
DOI: 10.1016/j.arr.2023.102141.
View